What We Are

Establishment background

The Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biological Products
came in force in August 2020. RMAF was established to efficiently and systematically promote the ARM projects
through the establishment of a public-private ownership to realize and facilitate the intent and objectives of the legislation. 

History

  • Regenerative Medicine Acceleration Foundation (RMAF)

    Regenerative Medicine Acceleration Foundation (RMAF)

  • 2025

    01Designated as an Advanced Regenerative Medicine Clinical Research Activation Support (R&D) Business group

    2024

    102024 RMAF Annual Symposium to be held

    2023

    04Selected as the Cell-Based Artificial Blood Technology Development Project Group

    2022

    04Selected as the Essential Training Program for Advanced Regenerative Medicine Clinical Researchers (R&D)

    2021

    07Selected as the project group for supporting clinical research on advanced regenerative medicine

    03Designated as an Advanced Regenerative Medicine Support Institution

    02Established Regenerative Medicine Acceleration Foundation (RMAF)

  • Strategic Center for Regenerative Medicine (SCRM)

    Strategic Center for Regenerative Medicine (SCRM)

  • 2020

    Supported the establishment of advanced regenerative medicine development strategies for the intermediate to long-term

  • Global Stem Cell and Regenerative Medicine Acceleration Center (GSRAC)

    Global Stem Cell and Regenerative Medicine Acceleration Center (GSRAC)

  • 2011

    Supported the development of production and manufacturing technology and the establishment of industrial foundation

close